7 research outputs found
Erratum: Publics and biobanks: Pan-European diversity and the challenge of responsible innovation (European Journal of Human Genetics (2012) DOI: 10.1038/ejhg.2012.104)
Public perceptions of cohort studies and biobanks in Germany
Cohort studies and biobank projects have led to public discussions in several European countries in the past. In Germany, many medium-sized studies are currently running successfully in terms of respondent rates. However, EU-wide research on general public perceptions of biobanks and cohort studies have shown that Germany is among those countries where people express the highest reluctance for providing body material and other data for research purposes. Because of early efforts of the just-initiated German National Cohort Study, we are able to begin to investigate in greater detail how various groups of people across Germany reflect and discuss the ongoing implementation of cohort studies and biobanking in Germany. Our research is based on 15 focus group discussions in four German regions, as well as on Eurobarometer poll data on biobanking
Erratum: Publics and biobanks: Pan-European diversity and the challenge of responsible innovation
Personal-genome tests a blurring the boundary between experts and lay people.
Personal-genome tests are blurring the boundary between experts and lay people. A team of international collaborators urge regulators to rethink outdated models of regulation.No Full Tex
Publics and biobanks: Pan-European diversity and the challenge of responsible innovation
This article examines public perceptions of biobanks in Europe using a multi-method approach combining quantitative and qualitative data. It is shown that public support for biobanks in Europe is variable and dependent on a range of interconnected factors: people’s engagement with biobanks; concerns about privacy and data security, and trust in the socio-political system, key actors and institutions involved in biobanks. We argue that the biobank community needs to acknowledge the impact of these factors if they are to successfully develop and integrate biobanks at a pan-European level